Serial Number
85141968
Owner
Taiwan Liposome Co., Ltd.Attorney
Joe McKinney MuncyFirst Use Date
Jul 1, 2010
Filing Date
Sep 30, 2010
TLC TAIWAN LIPOSOME COMPANY Trademark
Serial Number: 85141968 • Registration: 4475502
Trademark Classes
Owner Contact Info
11F-1, No.3, Yuan Cyu St., Nankang Dist.
Taipei , TW
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
September 30, 2010
Registration Date
January 28, 2014
First Use Anywhere
July 1, 2010
First Use in Commerce
November 1, 2010
Published for Opposition
January 8, 2013
Cancellation Date
August 9, 2024
Goods & Services
allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; biological preparations for medical purposes for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, non-infectious diseases, neurological diseases, and psychological conditions; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; fungal medications; hormones for medical purposes; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use, all containing or promoting the production of liposomes, all produced through lipid-based formulations and technologies
